![Gordon Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Gordon J.
Brooks currently works at Dermira, Inc., as Director from 2020, ARMO BioSciences, Inc., as Director from 2018, and Sigilon Therapeutics, Inc., as Director from 2023.
Actieve functies van Gordon Brooks
| Bedrijven | Functie | Begin |
|---|---|---|
| ARMO BIOSCIENCES INC | Directeur/Bestuurslid | 21-06-2018 |
| DERMIRA, INC. | Directeur/Bestuurslid | 20-02-2020 |
| SIGILON THERAPEUTICS, INC. | Directeur/Bestuurslid | 11-08-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
48
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
